Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giacomo Coltro

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Current Oncology Reports|November 16, 2019
Chronic Myelomonocytic Leukemia: Insights into Biology, Prognostic Factors, and TreatmentGiacomo Coltro, Mrinal M Patnaik
Expert Opinion on Drug Safety|December 17, 2020
The safety of JAK kinase inhibitors for the treatment of myelofibrosisGiacomo Coltro, Alessandro M Vannucchi
Bioengineering (Basel, Switzerland)|May 27, 2023
The Role of Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Past, Present, and Future DirectionsMatteo Piccini, Francesco Mannelli, Giacomo Coltro
International Review of Cell and Molecular Biology|November 10, 2021
Classical Philadelphia-negative myeloproliferative neoplasms (MPNs): A continuum of different disease entitiesGiacomo Coltro, Giuseppe G Loscocco, Alessandro M Vannucchi
Cells|August 27, 2021
Integration of Molecular Information in Risk Assessment of Patients with Myeloproliferative NeoplasmsGiuseppe G Loscocco, Giacomo Coltro, Paola Guglielmelli, et al.
International Journal of Molecular Sciences|October 28, 2023
Hematologic Neoplasms Associated with Down Syndrome: Cellular and Molecular Heterogeneity of the DiseasesEdoardo Peroni, Michele Gottardi, Lucia D'Antona, et al.
European Journal of Clinical Investigation|June 9, 2016
Thrombotic risk correlates with mutational status in true essential thrombocythemiaIrene Bertozzi, Edoardo Peroni, Giacomo Coltro, et al.
Cancers|June 26, 2026
Cardiovascular Complications and Subclinical Myocardial Dysfunction in Patients Undergoing Hematopoietic Stem Cell TransplantationSabina Caciolli, Andrea Grasso Granchietti, Francesco Vanni, et al.
American Journal of Hematology|October 17, 2023
The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation-enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosisGiuseppe G Loscocco, Giada Rotunno, Francesco Mannelli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 30, 2025
Clinical and Prognostic Correlates of the Reticulin-Collagen-Osteosclerosis Score in Primary MyelofibrosisRaffaella Santi, Giacomo Coltro, Gioia Di Stefano, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Oncology Reports|November 16, 2019
Chronic Myelomonocytic Leukemia: Insights into Biology, Prognostic Factors, and TreatmentGiacomo Coltro, Mrinal M Patnaik
Expert Opinion on Drug Safety|December 17, 2020
The safety of JAK kinase inhibitors for the treatment of myelofibrosisGiacomo Coltro, Alessandro M Vannucchi
Bioengineering (Basel, Switzerland)|May 27, 2023
The Role of Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Past, Present, and Future DirectionsMatteo Piccini, Francesco Mannelli, Giacomo Coltro
International Review of Cell and Molecular Biology|November 10, 2021
Classical Philadelphia-negative myeloproliferative neoplasms (MPNs): A continuum of different disease entitiesGiacomo Coltro, Giuseppe G Loscocco, Alessandro M Vannucchi
Cells|August 27, 2021
Integration of Molecular Information in Risk Assessment of Patients with Myeloproliferative NeoplasmsGiuseppe G Loscocco, Giacomo Coltro, Paola Guglielmelli, et al.
International Journal of Molecular Sciences|October 28, 2023
Hematologic Neoplasms Associated with Down Syndrome: Cellular and Molecular Heterogeneity of the DiseasesEdoardo Peroni, Michele Gottardi, Lucia D'Antona, et al.
European Journal of Clinical Investigation|June 9, 2016
Thrombotic risk correlates with mutational status in true essential thrombocythemiaIrene Bertozzi, Edoardo Peroni, Giacomo Coltro, et al.
Cancers|June 26, 2026
Cardiovascular Complications and Subclinical Myocardial Dysfunction in Patients Undergoing Hematopoietic Stem Cell TransplantationSabina Caciolli, Andrea Grasso Granchietti, Francesco Vanni, et al.
American Journal of Hematology|October 17, 2023
The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation-enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosisGiuseppe G Loscocco, Giada Rotunno, Francesco Mannelli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 30, 2025
Clinical and Prognostic Correlates of the Reticulin-Collagen-Osteosclerosis Score in Primary MyelofibrosisRaffaella Santi, Giacomo Coltro, Gioia Di Stefano, et al.
Pageof 2